Approaches for the sequence-specific knockdown of mRNA

Nature Biotechnology

Volumn 21, Issue 12, 2003, Pages 1457-1465

  Scherer, Lisa J ^a   Rossi, John J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERIVATIVES; DNA; GENES; RNA;

GENE FUNCTIONS;

BIOTECHNOLOGY;

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; RIBOZYME;

GENE DELIVERY SYSTEM; GENE FUNCTION; GENE TARGETING; GENETIC STABILITY; PRIORITY JOURNAL; REVIEW; RNA SEQUENCE;

ANIMALS; BASE SEQUENCE; DNA, CATALYTIC; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; HUMANS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; RNA INTERFERENCE; RNA, CATALYTIC; RNA, MESSENGER; RNA, SMALL INTERFERING; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 0348014774     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt915     Document Type: Review

References (100)

1. Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in C. elegans. Nature 391, 806-811 (1998).
2. Elbashir, S.M. et al. Duplexes of 21-nucleotide RNA s mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
3. Caplen, N.J., Parrish, S., Imani, F., Fire, A. & Morgan, R.A. Specific inhibition of gene expression by small double-stranded RNA s in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA 98, 9742-9747 (2001).
4. Stephenson, M.L. & Zamecnik, RC. Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc. Natl. Acad. Sci. USA 75, 285-288 (1978).
5. Zamecnik, P.C. & Stephenson, M.L. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 75, 280-284 (1978).
6. Crooke, S.T. Molecular mechanisms of action of antisense drugs. Biochem. Biophys. Acta. 1489, 31-44 (1999).
7. Branch, A.D. A hitchhiker's guide to antisense and nonantisense biochemical pathways. Hepatology 24, 1517-1529 (1996).
8. Dias, N. & Stein, C.A. Antisense oligonucleotides; basic concepts and mechanisms. Mol. Cancer Ther. 1, 347-355 (2002).
9. Stein, C.A. & Cohen, J.S. Oligodeoxynucleotides as inhibitors of gene expression: a review. Cancer Res. 48, 2659-2668 (1988).
10. Zon, G. Innovations in the use of antisense oligonucleotides. Ann. NY Acad. Sci. 616, 161-172 (1990).
11. Kruger, K. etal. Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of Tetrahymena, Cell 31, 147-157 (1982).
12. Bevilacqua, P.C. & Turner, D.H. Comparison of binding of mixed ribose-deoxyribose analogues of CUCU to a ribozyme and to GGAGAA by equilibrium dialysis; evidence for ribozyme specific interactions with 2′ OH groups, Biochemistry 30, 10632-10640 (1991).
13. Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N. & Altman, S. The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857 (1983).
14. Costa, M. & Michel, F. Frequent use of the same tertiary motif by self-folding RNAs. EMBO J. 14, 1276-1285 (1995).
15. Hutchins, C.J., Rathjen, P.D., Forster, A.C., & Symons, R.H. Self-cleavage of plus and minus RNA transcripts of avocado sunblotch viroid, Nucleic Acids Res. 14, 3627-3640 (1986).
16. Buzayan, J.M., McNinch, J.S., Schneider, I.R. & Bruening, G. A nucleotide sequence rearrangement distinguishes two isolates of satellite tobacco ringspot virus RNA. Virology 160, 95-99 (1987).
17. Buzayan, J.M., Hampel, A. & Bruening, G. Nucleotide sequence and newly formed phosphodiester bond of spontaneously ligated satellite tobacco ringspot virus RNA. Nucleic Acids Res. 14, 9729-9743 (1986).
18. Kumar, P.K. et al. Random mutations to evaluate the role of bases at two important single-stranded regions of genomic HDV ribozyme. Nucleic Acids Res. 20, 3919-3924 (1992).
19. Saville, B.J. & Collins, R.A. A site-specific self-cleavage reaction performed by a novel RNA in Neurospora mitochondria. Cell 61, 685-696 (1990).
20. Wilson, D.S. & Szostak, J.W. In vitroselection of functional nucleic acids. Annu. Rev. Biochem. 68, 611-647 (1999).
21. Szostak, J.W. Enzymatic activity of the conserved core of a group I self-splicing intron. Nature 322, 83-86 (1986).
22. Jones, J.T., Lee, S.W. & Sullenger, B.A. Trans-splicing reactions by ribozymes. Methods Mol. Biol. 74, 341-348 (1997).
23. Sullenger, B.A. & Cech, T.R. Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing. Nature 371, 619-622 (1994).
24. Lan, N. et al. Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA. Mol. Ther. 2, 245-255 (2000).
25. Lan, N., Howrey, R.P., Lee, S.W., Smith, C.A. & Sullenger, B.A. Ribozyme-mediated repair of sickle beta-globin mRNAs in erythrocyte precursors. Science 280, 1593-1596 (1998).
26. Watanabe, T. & Sullenger, B.A. Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc. Natl. Acad. Sci. USA 97, 8490-8494 (2000).
27. Phylactou, L.A., Darrah, C. & Wood, M.J. Ribozyme-mediated trans-splicing of a trinucleotide repeat. Nat. Genet. 18, 378-381 (1998).
28. Kurz, J.C. & Fierke, C.A. Ribonuclease P: a ribonucleoprotein enzyme. Curr. Opin, Chem. Biol. 4, 553-558 (2000).
29. Forster, A.C. & Altman, S. External guide sequences for an RNA enzyme. Science 249, 783-786 (1990).
30. Ikawa, Y., Shiraishi, H. & Inoue, T. Trans-activation of the Tetrahymena ribozyme by its P2-2.1 domains. J. Biochem. (Tokyo) 123, 528-533 (1998).
31. Duhamel, J. et al. Secondary structure content of the HDV ribozyme in 95% formamide. Nucleic Acids Res. 24, 3911-3917 (1996).
32. Trang, P., Kilani, A., Kim, J. & Liu, F. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1. J. Mol. Biol. 301, 817-826 (2000).
33. Kilani, A.F. et al. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture. J. Biol. Chem. 275, 10611-10622 (2000).
34. Dunn, W., Trang, P., Khan, U., Zhu, J. & Liu, F. RNase P-mediated inhibition of cytomegalovirus protease expression and viral DNA encapsidation by oligonucleotide external guide sequences, Proc. Natl. Acad. Sci. USA 98, 14831-14836 (2001).
35. Trang, P. et al. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding. J. Mol. Biol. 315, 573-586 (2002).
36. Trang, P. et al. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli. Proc. Natl. Acad. Sci. USA 97, 5812-5817 (2000).
37. Forster, A.C., Jeffries, A.C., Sheldon, C.C. & Symons, R.H. Structural and ionic requirements for self-cleavage of virusoid RNAs and trans self-cleavage of viroid RNA. Cold Spring Harb. Symp. Quant. Biol. 52, 249-259 (1987).
38. Haseloff, J. & Gerlach, W.L. Simple RNA enzymes with new and highly specific endoribonuclease activities. Biotechnology 24, 264-269 (1992).
39. Hampel, A., Tritz, R., Hicks, M. & Cruz, P. 'Hairpin' catalytic RNA model: evidence for helices and sequence requirement for substrate RNA Nucleic Acids Res. 18, 299-304 (1990).
40. Haseloff, J. & Gerlach, W.L. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334, 585-591 (1988).
41. Sarver, N. et al. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222-1225 (1990).
42. Opalinska, J.B. & Gewirtz, A.M. Nucleic-acid therapeutics: basic principles and recent applications. Nat. Rev. Drug Discov. 1, 503-514 (2002).
43. Sullenger, B.A. & Gilboa, E. Emerging clinical applications of RNA. Nature 418, 252-258 (2002).
44. Rossi, J.J. The application of ribozymes to HIV infection. Curr. Opin. Mol. Ther. 1, 316-322 (1999).
45. Rossi, J.J. Therapeutic applications of catalytic antisense RNAs (ribozymes). Ciba Found. Symp. 209, 195-204 (1997).
46. Couture, L.A. & Stinchcomb, D.T. Anti-gene therapy: the use of ribozymes to inhibit gene function. Trends Genet. 12, 510-515 (1996).
47. Santoro, S.W. & Joyce, G.F. A general purpose RNA-cleaving DNA enzyme. Proc. Natl. Acad. Sci. USA 94, 4262-4266 (1997).
48. Santoro, S.W. & Joyce, G.F. Mechanism and utility of an RNA-cleaving DNA enzyme. Biochemistry 37, 13330-13342 (1998).
49. Khachigian, L.M. DNAzymes: cutting a path to a new class of therapeutics. Curr. Opin. Mol. Ther. 4, 119-121 (2002).
50. Emilsson, G.M. & Breaker, R.R. Deoxyribozymes: new activities and new applications. Cell Mol. Life Sci. 59, 596-607 (2002).
51. Cairns, M.J., Saravolac, E.G. & Sun, L.Q. Catalytic DNA: a novel tool for gene suppression. Curr. Drug Targets 3, 269-279 (2002).
52. Zhang, L. et al. Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor 2. Cancer Res. 62, 5463-5469 (2002).
53. Wu, Y. et al. Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes). Hum. Gene Ther. 10, 2847-2857 (1999).
54. Bernstein, E., Caudy, A.A., Hammond, S.M. & Hannon, G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366 (2001).
55. Volpe, T.A. et al. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297, 1833-1837 (2002).
56. Reinhart, B.J. & Bartel, D.P. Small RNAs correspond to centromere heterochromatic repeats. Science 297, 1831 (2002).
57. Hall, I.M. et al. Establishment and maintenance of a heterochromatin domain. Science 297, 2232-2237 (2002).
58. Schramke, V. & Allshire, R. Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing. Science 301, 1069-1074 (2003).
59. Sledz, C.A., Holko, M., De Veer, M.J., Silverman, R.H. & Williams, B.R. Activation of the interferon system by short-interfering RNAS. Nat. Cell Biol. 5, 834-839 (2003).
60. Lee, Y. et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425, 415-419 (2003).
61. Schwarz, D.S. et al. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208 (2003).
62. Zeng, Y. & Cullen, B.R. Sequence requirements for micro RNA processing and function in human cells. RNA 9, 112-123 (2003).
63. Carrington, J.C. & Ambros, V. Role of microRNAs in plant and animal development. Science 301, 336-338 (2003).
64. Lim, L.P., Glasner, M.E., Yekta, S., Burge, C.B. & Bartel, D.P. Vertebrate microRNA genes. Science 299, 1540 (2003).
65. Hutvagner, G. & Zamore, P.D. RNAi: nature abhors a double-strand. Curr. Opin. Genet. Dev. 12, 225-232 (2002).
66. Doench, J.G., Petersen, C.P. & Sharp, P.A. siRNAs can function as miRNAs. Genes Dev. 17, 438-442 (2003).
67. Zeng, Y., Wagner, E.J. & Cullen, B.R. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell 9, 1327-1333 (2002).
68. Tuschl, T. Expanding small RNA interference. Nat. Biotechnol. 20, 446-448 (2002).
69. Zeng, Y. & Cullen, B.R. RNA interference in human cells is restricted to the cytoplasm. RNA 8, 855-860 (2002).
70. Michienzi, A., Cagnon, L., Bahner, I. & Rossi, J.J. Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA. Proc. Natl. Acad. Sci. USA 97, 8955-8960 (2000).
71. Grunweller, A. et al. Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2′-O-methyl RNA, phosphorothioates and small interfering RNA. Nucleic Acids Res. 31, 3185-3193 (2003).
72. Vickers, T.A. et al. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J. Biol. Chem. 278, 7108-7118 (2003).
73. Holen, T., Amarzguioui, M., Wiiger, M.T., Babaie, E. & Prydz, H. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucleic Acids Res. 30, 1757-1766 (2002).
74. Bohula, E.A. et al. The efficacy of small interfering RNAs targeted to the type 1 insulin-like growth factor receptor (IGF1R) is influenced by secondary structure in the IGF1R transcript. J. Biol. Chem. 278, 15991-15997 (2003).
75. Rossi, J.J. Ribozymes, genomics and therapeutics. Chem. Biol. 6, R33-R37 (1999).
76. Khvorova, A., Reynolds, A. & Jayasena, S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 209-216 (2003).
77. Lee, N.S. et al. Functional colocalization of ribozymes and target mRNAs in Drosophila oocytes. FASEB J. 15, 2390-2400 (2001).
78. Lee, N.S., Bertrand, E. & Rossi, J. mRNA localization signals can enhance the intracellular effectiveness of hammerhead ribozymes. RNA 5; 1200-1209 (1999).
79. Castanotto, D., Scherr, M. & Rossi, J.J. Intracellular expression and function of anti-sense catalytic RNAs. Methods Enzymol. 313, 401-420 (2000).
80. Sullenger, B.A. Colocalizing ribozymes with substrate RNAs to increase their efficacy asgene inhibitors. Appl. Biochem. Biotechnol. 54, 57-61 (1995).
81. Kawasaki, H. & Taira, K. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res. 31, 700-707 (2003).
82. Giles, R.V. & Tidd, D.M. Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures. Nucleic Acids Res. 20, 763-770 (1992).
83. Millington-Ward, S. et al. A mutation-independent therapeutic strategem for osteogenesis imperfecta. Antisense Nucleic Acid Drug. Dev. 9, 537-542 (1999).
84. Drenser, K.A., Timmers, A.M., Hauswirth, W.W. & Lewin, A.S. Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 39, 681-689 (1998).
85. Lewin, A.S. et al. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat. Med. 4, 967-971 (1998).
86. Jackson, A.L. et al. Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21, 635-637 (2003).
87. Chi, J.T. etal. Genome-wide view of gene silencing by small interfering RNAs. Proc. Natl. Acad. Sci. USA 100, 6343-6346 (2003).
88. Krieg, A.M. CpG motifs in bacterial DNA and their Immune effects. Annu. Rev. Immunol. 20, 709-760 (2002).
89. Mirmohammadsadegh, A., Maschke, J., Basner-Tschakarjan, E., Bar, A. & Hengge, U.R. Induction of acute phase response genes in keratinocytes following exposure to oligodeoxynucleotides. J. Mol. Med. 80, 377-383 (2002).
90. Gewirtz, A.M. Oligonucleotide therapeutics: clothing the emperor. Curr. Opin. Mol. Ther. 1, 297-306 (1999).
91. Bridge, A.J., Pebernard, S., Ducraux, A., Nicoulaz, A.L. & Iggo, R. Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263-264 (2003).
92. Matsukura, S., Jones, P.A. & Takai, D. Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res. 31, e77 (2003).
93. Chen, Y., Stamatoyannopoulos, G. & Song, C.Z. Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro. Cancer Res. 63, 4801-4804 (2003).
94. Chiu, Y.L. & Rana, T.M. siRNA function in RNAi: a chemical modification analysis. RNA 9, 1034-1048 (2003).
95. Fortes, P. et al. Inhibiting expression of specific genes in mammalian cells with 5′ end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA. Proc. Natl. Acad. Sci. USA 100, 8264-8269 (2003).
96. Editorial. Whither RNAi? Nat. Cell. Biol. 5, 489-490 (2003).
97. Bartel, D. Whither RNAi? Nat. Cell. Biol. 5, 489-490 (2003).
98. Scott, W.G., Finch, J.T. & Klug, A. The crystal structure of an all-RNA hammerhead ribozyme. Nucleic Acids Symp. Ser. 34, 214-216 (1995).
99. Pley, H.W., Flaherty, K.M. & McKay, D.B. Three-dimensional structure of a hammer-head ribozyme. Nature 372, 68-74 (1994).
100. Hertel, K.J. et al. Numbering system for the hammerhead. Nueclic Acids Res. 20, 3252 (1992).